Dr. David C. Madoff is Vice Chairman for Academic Affairs and Professor of Radiology at Weill Cornell Medical College and an Attending Physician at NewYork-Presbyterian/Weill Cornell. He is an internationally-recognized expert in Interventional Oncology, a subspecialty within Interventional Radiology that offers patients with various forms of cancer minimally invasive curative, adjuvant and palliative treatment options. Dr. Madoff earned his B.A. from Emory University and his M.D. from the University of Pittsburgh. He completed both his internship in Internal Medicine and residency in Radiology at SUNY at Stony Brook and his fellowship training in Vascular and Interventional Radiology at The University of Texas MD Anderson Cancer Center.
Dr. Madoff achieved Board Certification in Diagnostic Radiology from the American Board of Radiology in 2000 and attained his Certificate of Added Qualifications in Vascular and Interventional Radiology in 2002.
He was a faculty member in the Section of Interventional Radiology at MD Anderson Cancer Center in Houston, Texas for a decade before joining Weill Cornell in 2011. From January 2011 to November 2015, Dr. Madoff served as Chief of the Division of Interventional Radiology. Under his leadership, the division experienced tremendous growth clinically and academically and regained its prominence as one of the leading Divisions of Interventional Radiology in the nation.
Dr. Madoff has a strong background in clinical care and has treated many patients with complex oncological problems. His clinical interests are wide-ranging, and have included visceral vascular, hepatobiliary and genitourinary interventions, various embolotherapy and percutaneous biopsy techniques and many specialized therapies within the realm of Interventional Oncology. In particular, Dr. Madoff is world-renowned for his work on preoperative portal vein embolization, a technique used to improve the safety of major hepatic resection. This technique is based on the liver's ability to regenerate and has been used in patients with primary and metastatic hepatobiliary cancer to increase the size of the anticipated liver remnant before surgery. Without this procedure, many patients with potentially resectable disease would not be eligible for curative resection. Dr. Madoff has also been heavily involved in treating patients with transarterial and ablative approaches to cancer in the liver and other organ systems.
Aetna [HMO, Medicare, PPO]
Aetna [Weill Cornell Employee Plan]
Affinity [Essential (Exchange)]
Emblem Select Care
Empire Blue Cross Blue Shield [Blue Priority, Child Health Plus, EPO, HMO, Mediblue (Senior), Pathway (Exchange), PPO]
Empire Blue Cross Blue Shield [Pathway Enhanced]
Health Insurance Plan of NY (HIP) [Medicaid, Medicare]
Oxford Health Plans [Freedom, Liberty, Medicare Advantage]
Rockefeller University - CoreSource
UnitedHealthcare [Community Plan, Compass (Exchange), HMO, Medicare]
1995 University of Pittsburgh School of Medicine
Internship: 1996 Stony Brook University Medical Center
Residency: 2000 Stony Brook University Medical Center
Fellowship: 2001 MD Anderson Cancer Center